For a precise analysis of the cholecystokinin (CCK 8) effects on human stomach, we dissected strips of longitudinal and circular muscle from the fundus, corpus and antrum, and circular muscle from the inner and outer pyloric sphincter and duodenum. Specimens were taken during gastrectomy and from stomachs of kidney donors. Mechanical activity was simultaneously recorded under auxotonic conditions. After CCK 8 application, the following effects were observed: (1) direct excitatory effects of CCK 8 with great regional variations in quality and intensity; (2) increases in amplitude of phasic contractions in the outer plyorus and longitudinal antrum (in the other types of preparations the effects were negligible; (3) increases in tonic activity in preparations of the proximal stomach and in strips of longitudinal muscle form the antrum, and (4) remarkable interindividual differences, with negligible responses in one third of the 24 human stomachs examined.

Journal Section:
Original Paper
Keywords:
Cholecystokinin, Human gastric motility, Isolated smooth muscle
This content is only available via PDF.
© 1988 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
1988
You do not currently have access to this content.